Sign inJoin waitlistJoin the waitlist

HB

Herman Van Besien

Credentials: · ·

History

Hematology and Medical Oncology
New York Presbyterian Hospital
2023–2026
Internal Medicine
University of Pennsylvania Health System
2020–2023
New York University Grossman School of Medicine
2016–2020

Research

Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma
Molecular Cancer Therapeutics · 2017 · 72 citations
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes
Blood Advances · 2020 · 40 citations
Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
Review · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · First of 4 authors · 17 citations

Samuel Yamshon
5 papers
NE
Neela Easton
3 papers · 3 as a fellow
Ethel Cesarman
2 papers
Juliet Barker
2 papers
Michelle Pasciolla
2 papers
Reid Merryman
2 papers
RS
Roni Shouval
2 papers · 1 as a fellow
Tsiporah Shore
2 papers
Ajay Gopal
1 paper
Amer Assal
1 paper
AC
Amy Chadburn
1 paper
Anath Lionel
1 paper · 1 as a fellow